Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells

IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells

US Patent 12202904 · Granted Jan 21, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for producing psicose from fructose-containing substrate2025
System and method for foreign object detection in wireless power transfer2025
Method for producing psicose2024
Methods and compositions for reducing immunosuppression by tumor cells2023
Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate2023
Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate2023
IL-23R antagonists to reprogram intratumoral T regulatory cells into effector ce2023
IL-23R antagonists to reprogram intratumoral T regulatory cells into effector ce2023
IL-23R antagonists to reprogram intratumoral T regulatory cells into effector ce2023
Image sensor and manufacturing method thereof2022
Intracellular osteopontin regulates the lineage commitment of lymphoid subsets2022
Inhibiting reduction of lean body mass and inhibiting accumulation of liver fat 2022